BLCO, CA0717051076

Bausch + Lomb stock at USD 16.49 on October 16, 2026, 18.01 percent below consensus

Published on 10/17/2026 at 22:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Results are due October 28, 2026. Bausch + Lomb stock stood at USD 16.49 on October 16, 2026, down 1.02 percent versus USD 16.66 at the NYSE.

Analyst target and reporting date

  • MarketBeat listed a USD 19.46 average target on October 17, 2026.
  • Bausch + Lomb scheduled third-quarter results for October 28, 2026.
  • Bausch + Lomb stock stood at USD 16.49 on October 16, 2026 at 4:00 p.m. ET, down 1.02 percent versus USD 16.66.
  • The company had a USD 5.9 billion market capitalization on October 16, 2026.
BLCO, CA0717051076, Illustration mit AI erstellt.

Bausch + Lomb stock stood at USD 16.49 on October 16, 2026, while the average analyst target was USD 19.46, leaving the target 18.01 percent above the price. MarketBeat said on October 17, 2026 that fifteen brokerages held a consensus Hold rating.

The latest scheduled reporting date gives the stock its next measurable test. Bausch + Lomb lists third-quarter 2026 results for October 28, 2026 at 8:00 a.m. ET.

Range and trading position

The October 16, 2026 NYSE price was 12.84 percent below the 52-week high of USD 18.92 and 14.20 percent above the 52-week low of USD 14.44. Trading volume was 419,845 shares, 6.56 percent below the average volume of 449,340 shares.

Valuation and operating marker

Bausch + Lomb had a market capitalization of USD 5.9 billion on October 16, 2026 and a negative trailing P/E ratio of 34.48. Its current full-year adjusted EBITDA guidance stood between USD 1.025 billion and USD 1.075 billion, according to Reuters on October 12, 2026.

Reuters also reported that Brent Saunders had departed as chief executive officer on October 12, 2026, with Thomas J. Appio becoming interim chief executive officer. The report said the company expected to raise its 2026 adjusted EBITDA forecast, while the current range remained USD 1.025 billion to USD 1.075 billion.

Comparison with peers

Bausch + Lomb: minus 1.02 percent, P/E minus 34.48, market capitalization USD 5.9 billion.

Alcon (NYSE, USD): minus 0.60 percent, P/E 50.91, market capitalization USD 32.0 billion.

Cooper Companies (NYSE, USD): plus 0.94 percent, P/E 19.77, market capitalization USD 11.0 billion.

Next trading reference

The October 16, 2026 NYSE close leaves Bausch + Lomb below its 52-week high but above its annual low, while the October 28 results date supplies the next company-specific event for the valuation discussion.

Market context: Market report S&P 500.

More news and analyses on Bausch + Lomb stock

Bausch + Lomb market details

  • Company: Bausch + Lomb Corporation
  • ISIN: CA0717051076
  • Ticker: BLCO
  • Primary exchange: NYSE and TSX
  • Price on NYSE: USD 16.49 as of October 16, 2026 at 4:00 p.m. ET
  • Change versus prior NYSE close: minus 1.02 percent
  • Market capitalization: USD 5.9 billion as of October 16, 2026
  • 52-week range: USD 14.44-18.92 as of October 16, 2026
  • Sector / Industry: Health Care / Eye health
Disclaimer...
en | CA0717051076 | BLCO | boerse | 70351195 | bgmi